Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Announced that The Brazilian regulatory agency ANVISA has ap...

Announced that The Brazilian regulatory agency ANVISA has approved the commencement of additional Phase 3 clinical trials of Leronlimab in certain Novel Coronavirus-19 patients.
The trial will focus on hospitalized critically ill patients requiring mechanical and invasive ventilation or extracorporeal membrane oxygenation. $CYTODYN INC (CYDY.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
4346 Views
Comment
Sign in to post a comment
    259Followers
    17Following
    576Visitors
    Follow